In Primary Care, Is Measuring Free-Thyroxine Plus Thyroid-Stimulating Hormone to Detect Hypopituitarism Cost-Effective? A Cost Utility Analysis Using Markov Chain Models

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2019-029369
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ


Related search